Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sérgio Neves

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
European Journal of Heart Failure|September 17, 2022
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialJoão Pedro Ferreira, João Sérgio Neves
European Journal of Heart Failure|September 14, 2022
Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewindJoão Pedro Ferreira, João Sérgio Neves
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure"João Pedro Ferreira, João Sérgio Neves
Frontiers in Endocrinology|May 30, 2023
Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatmentJoão Sérgio Neves, Martin Buysschaert, Michael Bergman
Lancet (London, England)|February 15, 2025
Effects of semaglutide on heart failure outcomesJoão Sérgio Neves, Milton Packer, João Pedro Ferreira
Nutrients|June 27, 2025
Glycemic Control and Quality of Life Among People with Type 1 Diabetes: Relationships with Insulin Therapy and Carbohydrate CountingRui Jorge Dias, João Sérgio Neves, Rui Poínhos
Journal of Cardiac Failure|June 5, 2024
Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?João Pedro Ferreira, Luís Mendonça, João Sérgio Neves
Journal of Nephrology|June 9, 2022
Association of combined fractional excretion of phosphate and FGF23 with heart failure and cardiovascular events in moderate and advanced renal diseaseLuís Mendonça, Miguel Bigotte Vieira, João Sérgio Neves
Journal of Cardiac Failure|April 7, 2023
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT TrialsJoão Sérgio Neves, Milton Packer, João Pedro Ferreira
Journal of Cardiac Failure|December 21, 2023
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are NeededJoão Pedro Ferreira, João Sérgio Neves, Francisca Saraiva
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Heart Failure|September 17, 2022
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialJoão Pedro Ferreira, João Sérgio Neves
European Journal of Heart Failure|September 14, 2022
Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewindJoão Pedro Ferreira, João Sérgio Neves
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure"João Pedro Ferreira, João Sérgio Neves
Frontiers in Endocrinology|May 30, 2023
Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatmentJoão Sérgio Neves, Martin Buysschaert, Michael Bergman
Lancet (London, England)|February 15, 2025
Effects of semaglutide on heart failure outcomesJoão Sérgio Neves, Milton Packer, João Pedro Ferreira
Nutrients|June 27, 2025
Glycemic Control and Quality of Life Among People with Type 1 Diabetes: Relationships with Insulin Therapy and Carbohydrate CountingRui Jorge Dias, João Sérgio Neves, Rui Poínhos
Journal of Cardiac Failure|June 5, 2024
Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?João Pedro Ferreira, Luís Mendonça, João Sérgio Neves
Journal of Nephrology|June 9, 2022
Association of combined fractional excretion of phosphate and FGF23 with heart failure and cardiovascular events in moderate and advanced renal diseaseLuís Mendonça, Miguel Bigotte Vieira, João Sérgio Neves
Journal of Cardiac Failure|April 7, 2023
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT TrialsJoão Sérgio Neves, Milton Packer, João Pedro Ferreira
Journal of Cardiac Failure|December 21, 2023
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are NeededJoão Pedro Ferreira, João Sérgio Neves, Francisca Saraiva
Pageof 17